Phenotypic age acceleration and early-onset lung cancer: a case–control and prognostic cohort study involving multiple clinical centres with validation in the UK Biobank
National Natural Science Foundation of China (no. 82303969); Beijing Xisike Clinical Oncology Research Foundation (no. Y-2024AZ [EGFR]MS-0079); Beijing Natural Science Foundation (no. 7222144).
Authors
- Xiaowei Zhao (ORCID: https://orcid.org/0000-0003-4978-3328)
- Wei Zhuang (ORCID: https://orcid.org/0000-0002-9845-2122)
- Yan Cheng (ORCID: https://orcid.org/0000-0001-5601-8160)
- Jianchun Duan
- Zhijian Xu
- Jiachen Xu
- Boyang Sun
- Yuxuan Liao
- Rui Wan
- Zhijie Wang
- Qinxiang Guo
- Jie Wang
- Hua Bai
- Qiwen Zheng
- Kailun Fei
- Jia Zhong
- Ruolin Gao
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- Beijing Institute of Genomics (CN)
- National Cancer Center (US)
- Shanxi Provincial Cancer Hospital (CN)
- First Affiliated Hospital of Henan University (CN)
Publication Details
- Journal
- EBioMedicine
- Published
- 2026-02-10
- DOI
- https://doi.org/10.1016/j.ebiom.2026.106162
- Primary Topic
- Lung Cancer Treatments and Mutations
- Type
- article
- Field-Weighted Citation Impact
- 0.00